BREAKING EXCLUSIVE: CEO Pardew's Last Day At CCRM Friday

CCRM's is Second Fertility Network Chief to Step Down in as Many Months

 

BY RON SHINKMAN, special to Inside Reproductive Health

The chief executive officer and president of one of the nation’s largest fertility clinics is stepping down, Inside Reproductive Health has learned. It’s the second exit of a head of a large reproductive health  provider in recent weeks.

Jon Pardew’s last day with the Lone Tree, Colo.-based CCRM Fertility is scheduled for this Friday, Oct. 21, a source inside the company said. He has been working remotely for an unspecified period of time.

While an exact reason has not been discerned for Pardew’s departure, a source familiar with the situation said it was health-related but not life-threatening. Pardew and a CCRM spokesperson did not respond to emails and phone calls seeking comment.

The 51-year-old Pardew has led CCRM and its affiliate companies since October 2013. At the time, it operated single clinics in Colorado and Houston and was then known as the Colorado Center for Reproductive Medicine.

CCRM Fertility has grown dramatically during Pardew’s tenure. It now operates 22 clinics in nine states, as well as two additional clinics in Canada. Its most recent acquisition occurred over the summer, when it acquired The Institute for Reproductive Medicine & Science (IRMS) , which has offices in both New York and New Jersey.

Revenue data for the privately-held CCRM Fertility, purchased by Unified Women's Healthcare from TA Associates in 2021, is not available, although GrowJo and ZoomInfo estimate it is between $75 million and $80 million per year.

Industry observers praised Pardew’s leadership.

“Jon was an incredibly thoughtful leader who approached his work as a service. He led the organization with incredible integrity and strength through the pandemic (and always),” said Carol Lynn Curchoe, a former IVF lab supervisor with CCRM Fertility, in an email. “I admire his authenticity greatly.”

Richard Groberg, a Las Vegas-based finance and private equity executive who has worked extensively in the reproductive health space, said in an email that Pardew was “dedicated and
fair.”

Prior to his tenure at CCRM, Pardew served as a managing director at St. Charles Capital, a Denver-based boutique venture capital firm, a plant manager for General Mills and as a U.S. Army officer.

No succession plans have been announced at CCRM Fertility, and Pardew is still listed as the CEO and president on the company’s website as well as his LinkedIn profile. A source said that a recruitment firm has been retained by CCRM Fertility to find Pardew’s successor.

Both Curchoe and Groberg said it would be tough finding a replacement of Pardew’s caliber, but that the company should still fare well.

Along with Pardew’s departure, Mark Segal announced in late September he was stepping down as CEO of US Fertility, which operates 69 locations nationwide. Richard Jennings, current CEO of Generate Life Sciences, will replace him. Jennings has already been named to the US Fertility board.

Segal’s last day is Dec. 31. He will become chairman of the US Fertility board of directors upon leaving the CEO post, which he has held since the company formed in 2020. He had been the CEO of Shady Grove Fertility since 1997.  “Mark has been a powerful force in shaping US Fertility and the reproductive industry,” said Jay Rose, a managing director at Amulet Capital and a US Fertility board member.

The themes reported in this publication are those of the news. They do not reflect the views of Inside Reproductive Health, nor of the Advertiser

 
 

All external links active as of 10/18/22.

External links are being provided as a convenience and for informational purposes only; they do not constitute an endorsement or an approval by Fertility Bridge or Inside Reproductive Health of any of the products, services or opinions of the corporation or organization or individual. Neither Fertility Bridge nor Inside Reproductive Health bears responsibility for the accuracy, legality or content of the external site or for that of subsequent links. Contact the external site for answers to questions regarding its content.